Lifeboat Foundation

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses to making final diagnoses and care management decisions. The large-language model (LLM) artificial intelligence chatbot performed equally well in both primary care and emergency settings across all medical specialties. The research team’s results are published in the Journal of Medical Internet Research.

Our paper comprehensively assesses decision support via ChatGPT from the very beginning of working with a patient through the entire care scenario, from differential diagnosis all the way through testing, diagnosis, and management. No real benchmarks exists, but we estimate this performance to be at the level of someone who has just graduated from medical school, such as an intern or resident. This tells us that LLMs in general have the potential to be an augmenting tool for the practice of medicine and support clinical decision making with impressive accuracy.

Summary: Researchers successfully sequenced the entire Y chromosome, previously considered the most elusive part of the human genome.

This feat enhances DNA sequencing accuracy for this chromosome, aiding the identification of genetic disorders. Using state-of-the-art technologies, the team pieced together over 62 million letters of genetic code.

This breakthrough, in tandem with the previous reference genome T2T-CHM13, offers the first complete genome for those with a Y chromosome.

Shares of Taiwan Semiconductor Manufacturing Corp, which manufactures all of Nvidia’s advanced AI semiconductors climbed as much as 1.81%

Mezli chef Eric Minnich designed a menu for both diner’s delight and ease of robotic cooking.

The only areas where AI is flourishing are shamming, spamming & scamming.

A new efficient system of cancer treatment using vitamin k3 (Vk3)-loaded copper zinc ferrite nanoparticles having therapeutic capabilities, could benefit millions of cancer patients worldwide.

With the ever-increasing prevalence of cancer cases worldwide, newer approaches to cancer therapy are increasingly needed to tackle the problem. Since conventional cancer therapies such as chemotherapy, radiation therapy and surgery have significant drawbacks such as resistance to chemotherapeutic drugs, adverse effects and lower efficacy, development of nanotherapies that can target hypoxic (when oxygen is not available in sufficient amounts at the tissue level) tumors, with minimum side-effects is necessary.

At present, magnetic hyperthermia-based cancer therapy (MHCT) therapy has been shown to be therapeutic. However, in most cases, it is not as effective due to the generation of lower levels of reactive oxygen species (ROS) in a hypoxic tumor microenvironment (TME) and low heat transmission.

Peter Diamandis is best known as the founder of the XPrize Foundation, which offers big cash prizes as an incentive for tech solutions to big problems. The entrepreneur and investor is also co-founder of the Singularity University, a Silicon Valley-based nonprofit offering education in futurology. His new book, The Future Is Faster Than You Think, argues that the already rapid pace of technological innovation is about to get a whole lot quicker.

Do you think people are worried about where technology is going to take us? I can palpably feel how fast things are changing and that the rate of change is accelerating, and I have picked up a growing amount of fear coming from people who don’t understand where the world is going. And that is not good when you’re trying to solve problems. This book is about giving people a roadmap for where things are going over the next decade so they have less fear and more anticipation. Because, yes, in the next 10 years, we’re going to reinvent every industry on this planet, but the change is one that is for the benefit of masses, whether it’s in longevity or food or banking.

Google is secretly showing off an AI tool that can produce news stories to major newspapers, including The New York Times, The Washington Post, and The Wall Street Journal.

The tool, dubbed Genesis, can digest public information and generate news content, according to reporting by the New York Times, in yet another sign that AI-generated — or at least AI-facilitated — content is about to flood the internet.

Google is stridently denying that the tool is meant to replace journalists, saying it will instead serve as a “kind of personal assistant for journalists, automating some tasks to free up time for others.”

Researchers from the University of Cambridge have unveiled a surprising discovery that holds the potential to reshape the landscape of electrochemical devices. This new insight opens the door for the creation of cutting-edge materials and paves the way for enhancements in sectors like energy storage, neuromorphic computing, and bioelectronics.

Electrochemical devices rely on the movement of charged particles, both ions, and electrons, to function properly. However, understanding how these charged particles move together has presented a significant challenge, hindering progress in creating new materials for these devices.

In the rapidly evolving field of bioelectronics, soft conductive materials known as conjugated polymers are used for developing medical devices that can be used outside of traditional clinical settings. For example, this type of material can be used to make wearable sensors that monitor patients’ health remotely or implantable devices that actively treat disease.